Zobrazeno 1 - 10
of 443
pro vyhledávání: '"Steven M. Devine"'
Autor:
Steven M. Devine
Publikováno v:
Cells, Vol 13, Iss 11, p 933 (2024)
NMDP recognizes that despite advances in hematopoietic stem cell transplantation (HSCT) and other cell therapies, not all patients have equitable access to treatment, and disparities in outcomes remain. This paper explores the recent work of NMDP to
Externí odkaz:
https://doaj.org/article/d77635f5e3f24e248d1d0afdc535e507
Autor:
William A. Wood, Deepika Dilip, Andriy Derkach, Natalie S. Grover, Olivier Elemento, Ross Levine, Gita Thanarajasingam, John A. Batsis, Charlotte Bailey, Arun Kannappan, Steven M. Devine, Andrew S. Artz, Jennifer A. Ligibel, Ethan Basch, Erin Kent, Jacob Glass
Publikováno v:
PLOS Digital Health, Vol 2, Iss 1 (2023)
Clinical performance status is designed to be a measure of overall health, reflecting a patient’s physiological reserve and ability to tolerate various forms of therapy. Currently, it is measured by a combination of subjective clinician assessment
Externí odkaz:
https://doaj.org/article/920e70d4be2e4a06885fc98db79fad95
Autor:
Nosha Farhadfar, Jeni Newman, Jennifer Novakovich, Jacklyn Barten, Eric T. Ndifon, Jason Oakes, Meghann Cody, Huy P. Pham, Jeffery J. Auletta, John P. Miller, Steven M. Devine, Heather E. Stefanski
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundThe Coronavirus Disease 2019 (COVID-19) pandemic in early 2020 has resulted in an unprecedented level of uncertainty and challenge for the stem cell donor registries. To address these challenges, rapid strategies were implemented by the Nat
Externí odkaz:
https://doaj.org/article/5aaa790c19104fba96094110ade32492
Autor:
Katiri J. Snyder, Hannah K. Choe, Yandi Gao, Natalie E. Sell, Kara M. Braunreiter, Nina C. Zitzer, Lotus Neidemire-Colley, Sonu Kalyan, Adrienne M. Dorrance, Andrea Keller, Maria M. Mihaylova, Satishkumar Singh, Lalit Sehgal, Gideon Bollag, Yan Ma, Ben Powell, Steven M. Devine, Parvathi Ranganathan
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Acute graft-versus-host disease (GVHD) is the leading cause of non-relapse mortality following allogeneic hematopoietic cell transplantation. The majority of patients non-responsive to front line treatment with steroids have an estimated overall 2-ye
Externí odkaz:
https://doaj.org/article/56efe39a20fb494faaa4960077ed69ab
Autor:
Polina Shindiapina, Maciej Pietrzak, Michal Seweryn, Eric McLaughlin, Xiaoli Zhang, Mat Makowski, Elshafa Hassan Ahmed, Sarah Schlotter, Rebecca Pearson, Rhonda Kitzler, Anna Mozhenkova, Jennifer Le-Rademacher, Richard F. Little, Gorgun Akpek, Ernesto Ayala, Steven M. Devine, Lawrence D. Kaplan, Ariela Noy, Uday R. Popat, Jack W. Hsu, Lawrence E. Morris, Adam M. Mendizabal, Amrita Krishnan, William Wachsman, Nita Williams, Nidhi Sharma, Craig C. Hofmeister, Stephen J. Forman, Willis H. Navarro, Joseph C. Alvarnas, Richard F. Ambinder, Gerard Lozanski, Robert A. Baiocchi
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
We report a first in-depth comparison of immune reconstitution in patients with HIV-related lymphoma following autologous hematopoietic cell transplant (AHCT) recipients (n=37, lymphoma, BEAM conditioning), HIV(-) AHCT recipients (n=30, myeloma, melp
Externí odkaz:
https://doaj.org/article/11e102a0fff440d19a1c2e8eecf7cba8
Autor:
Narendranath Epperla, Kwang Woo Ahn, Sairah Ahmed, Madan Jagasia, Alyssa DiGilio, Steven M. Devine, Samantha Jaglowski, Vanessa Kennedy, Andrew R. Rezvani, Sonali M. Smith, Anna Sureda, Timothy S. Fenske, Mohamed A. Kharfan-Dabaja, Phillipe Armand, Mehdi Hamadani
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-12 (2017)
Abstract Background In B cell non-Hodgkin lymphoma (B-NHL), rituximab-containing reduced-intensity conditioning regimens (R-RIC) have been shown to provide favorable outcomes in single-arm studies; however, large multicenter studies comparing R-RIC a
Externí odkaz:
https://doaj.org/article/4327f541cc4a4a5cb2c3d047f951ee3d
Autor:
Alice S. Mims, Anjali Mishra, Shelley Orwick, James Blachly, Rebecca B. Klisovic, Ramiro Garzon, Alison R. Walker, Steven M. Devine, Katherine J. Walsh, Sumithira Vasu, Susan Whitman, Guido Marcucci, Daniel Jones, Nyla A. Heerema, Gerard Lozanski, Michael A. Caligiuri, Clara D. Bloomfield, John C. Byrd, Richard Piekarz, Michael R. Grever, William Blum
Publikováno v:
Haematologica, Vol 103, Iss 6 (2018)
KMT2A partial tandem duplication occurs in approximately 5–10% of patients with acute myeloid leukemia and is associated with adverse prognosis. KMT2A wild type is epigenetically silenced in KMT2A partial tandem duplication; re-expression can be in
Externí odkaz:
https://doaj.org/article/64600a7ff8504256962fa5545939c604
Autor:
William Blum, Mitch A. Phelps, Rebecca B. Klisovic, Darlene M. Rozewski, Wenjun Ni, Katie A. Albanese, Brad Rovin, Cheryl Kefauver, Steven M. Devine, David M. Lucas, Amy Johnson, Larry J. Schaaf, John C. Byrd, Guido Marcucci, Michael R. Grever
Publikováno v:
Haematologica, Vol 95, Iss 7 (2010)
Background A pharmacokinetically derived schedule of flavopiridol administered as a 30 min intravenous bolus followed by 4-hour continuous intravenous infusion (IVB/CIVI) is active in fludarabine-refractory chronic lymphocytic leukemia, but no studie
Externí odkaz:
https://doaj.org/article/0067fbbaef9b4bf9a6db24460b917eb7
Autor:
Monzr M. Al Malki, Steven M Devine, Bronwen E. Shaw, Larisa Broglie, Muna Qayed, Sung W. Choi, Stephen R. Spellman, Craig Malmberg, Eric Ndifon, Brent Logan, Jeffery Auletta, Heather E Stefanski, Janelle A. Olson, Antonio Jimenez Jimenez
Publikováno v:
Blood. 140:7591-7593
Autor:
Heather E Stefanski, Stephanie Bo-Subait, Hati Kobusingye, Deborah Mattila, Michelle Kuxhausen, Jennifer Schenfeld, Darcie Sandschafer, Cisio De Oliveira Brandao, Linda J Burns, Bronwen E. Shaw, Michael A. Pulsipher, John P Miller, Steven M Devine
Publikováno v:
Blood. 140:10862-10864